Global GMP Drug Substance Market Growth (Status and Outlook) 2026-2032
The global GMP Drug Substance market size is predicted to grow from US$ 2617 million in 2025 to US$ 4016 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032.
GMP Drug Substance refers to biologically or chemically active materials manufactured under Good Manufacturing Practice (GMP) standards. It serves as the core raw material for drug product formulation, ensuring required safety, purity, and stability. It is essential for pharmaceutical development, clinical application, and commercialization.
Upstream raw materials for GMP drug substances include culture media, supplements (serum, serum-free replacements), buffers, raw chemicals, and excipients. Production technologies and equipment include cell lines, plasmid vectors, expression systems (CHO, E. coli, yeast, etc.), disposable reactors, bioreactors, purification systems (chromatography, filtration), and testing equipment. Downstream of GMP drug substances are primarily biopharmaceutical companies, where the bulk solution is formulated, filled, lyophilized, and packaged into the final biopharmaceutical.
United States market for GMP Drug Substance is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for GMP Drug Substance is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for GMP Drug Substance is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key GMP Drug Substance players cover WuXi Biologics, Lonza, Xikang(Wuhan)Biopharmaceutical, Bioworkshops, FUJIFILM Biotechnologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
This Insight Report provides a comprehensive analysis of the global GMP Drug Substance landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on GMP Drug Substance portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GMP Drug Substance market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GMP Drug Substance and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GMP Drug Substance.
This report presents a comprehensive overview, market shares, and growth opportunities of GMP Drug Substance market by product type, application, key players and key regions and countries.
GMP Drug Substance refers to biologically or chemically active materials manufactured under Good Manufacturing Practice (GMP) standards. It serves as the core raw material for drug product formulation, ensuring required safety, purity, and stability. It is essential for pharmaceutical development, clinical application, and commercialization.
Upstream raw materials for GMP drug substances include culture media, supplements (serum, serum-free replacements), buffers, raw chemicals, and excipients. Production technologies and equipment include cell lines, plasmid vectors, expression systems (CHO, E. coli, yeast, etc.), disposable reactors, bioreactors, purification systems (chromatography, filtration), and testing equipment. Downstream of GMP drug substances are primarily biopharmaceutical companies, where the bulk solution is formulated, filled, lyophilized, and packaged into the final biopharmaceutical.
United States market for GMP Drug Substance is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for GMP Drug Substance is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for GMP Drug Substance is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key GMP Drug Substance players cover WuXi Biologics, Lonza, Xikang(Wuhan)Biopharmaceutical, Bioworkshops, FUJIFILM Biotechnologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
Report Scope
LPI (LP Information)' newest research report, the “GMP Drug Substance Industry Forecast” looks at past sales and reviews total world GMP Drug Substance sales in 2025, providing a comprehensive analysis by region and market sector of projected GMP Drug Substance sales for 2026 through 2032. With GMP Drug Substance sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GMP Drug Substance industry.This Insight Report provides a comprehensive analysis of the global GMP Drug Substance landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on GMP Drug Substance portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GMP Drug Substance market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GMP Drug Substance and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GMP Drug Substance.
This report presents a comprehensive overview, market shares, and growth opportunities of GMP Drug Substance market by product type, application, key players and key regions and countries.
Market Segmentation
Segmentation by Type:
- Monoclonal Antibodies (mAbs)
- Recombinant Proteins/enzymes
- Antibody-drug Conjugates (ADCs)
- Vaccines
- Others
Segmentation by Application:
- Cancer
- Diabetes
- Disease Prevention
- Rare Diseases
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- WuXi Biologics
- Lonza
- Xikang(Wuhan)Biopharmaceutical
- Bioworkshops
- FUJIFILM Biotechnologies
- Ardena
- Catalent Biologics
- Hovione
- Cambrex
- Richter BioLogics
- Samsung Biologic
- CordenPharma
- Mabion
- Shenzhen Letu Life Technology
- Bio-Thera Solutions
- BioDlink Biopharm
- Nanjing Probio Biotech
- Shanghai Henlius Biotech
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GMP Drug Substance Market Size (2021-2032)
2.1.2 GMP Drug Substance Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for GMP Drug Substance by Country/Region (2021, 2025 & 2032)
2.2 GMP Drug Substance Segment by Type
2.2.1 Monoclonal Antibodies (mAbs)
2.2.2 Recombinant Proteins/enzymes
2.2.3 Antibody-drug Conjugates (ADCs)
2.2.4 Vaccines
2.2.5 Others
2.2.6 GMP Drug Substance Market Size by Type
2.2.6.1 GMP Drug Substance Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global GMP Drug Substance Market Size Market Share by Type (2021-2026)
2.3 GMP Drug Substance Segment by Application
2.3.1 Cancer
2.3.2 Diabetes
2.3.3 Disease Prevention
2.3.4 Rare Diseases
2.3.5 Others
2.3.6 GMP Drug Substance Market Size by Application
2.3.6.1 GMP Drug Substance Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.6.2 Global GMP Drug Substance Market Size Market Share by Application (2021-2026)
3 GMP DRUG SUBSTANCE MARKET SIZE BY PLAYER
3.1 GMP Drug Substance Market Size Market Share by Player
3.1.1 Global GMP Drug Substance Revenue by Player (2021-2026)
3.1.2 Global GMP Drug Substance Revenue Market Share by Player (2021-2026)
3.2 Global GMP Drug Substance Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GMP DRUG SUBSTANCE BY REGION
4.1 GMP Drug Substance Market Size by Region (2021-2026)
4.2 Global GMP Drug Substance Annual Revenue by Country/Region (2021-2026)
4.3 Americas GMP Drug Substance Market Size Growth (2021-2026)
4.4 APAC GMP Drug Substance Market Size Growth (2021-2026)
4.5 Europe GMP Drug Substance Market Size Growth (2021-2026)
4.6 Middle East & Africa GMP Drug Substance Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas GMP Drug Substance Market Size by Country (2021-2026)
5.2 Americas GMP Drug Substance Market Size by Type (2021-2026)
5.3 Americas GMP Drug Substance Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GMP Drug Substance Market Size by Region (2021-2026)
6.2 APAC GMP Drug Substance Market Size by Type (2021-2026)
6.3 APAC GMP Drug Substance Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe GMP Drug Substance Market Size by Country (2021-2026)
7.2 Europe GMP Drug Substance Market Size by Type (2021-2026)
7.3 Europe GMP Drug Substance Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GMP Drug Substance by Region (2021-2026)
8.2 Middle East & Africa GMP Drug Substance Market Size by Type (2021-2026)
8.3 Middle East & Africa GMP Drug Substance Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GMP DRUG SUBSTANCE MARKET FORECAST
10.1 Global GMP Drug Substance Forecast by Region (2027-2032)
10.1.1 Global GMP Drug Substance Forecast by Region (2027-2032)
10.1.2 Americas GMP Drug Substance Forecast
10.1.3 APAC GMP Drug Substance Forecast
10.1.4 Europe GMP Drug Substance Forecast
10.1.5 Middle East & Africa GMP Drug Substance Forecast
10.2 Americas GMP Drug Substance Forecast by Country (2027-2032)
10.2.1 United States Market GMP Drug Substance Forecast
10.2.2 Canada Market GMP Drug Substance Forecast
10.2.3 Mexico Market GMP Drug Substance Forecast
10.2.4 Brazil Market GMP Drug Substance Forecast
10.3 APAC GMP Drug Substance Forecast by Region (2027-2032)
10.3.1 China GMP Drug Substance Market Forecast
10.3.2 Japan Market GMP Drug Substance Forecast
10.3.3 Korea Market GMP Drug Substance Forecast
10.3.4 Southeast Asia Market GMP Drug Substance Forecast
10.3.5 India Market GMP Drug Substance Forecast
10.3.6 Australia Market GMP Drug Substance Forecast
10.4 Europe GMP Drug Substance Forecast by Country (2027-2032)
10.4.1 Germany Market GMP Drug Substance Forecast
10.4.2 France Market GMP Drug Substance Forecast
10.4.3 UK Market GMP Drug Substance Forecast
10.4.4 Italy Market GMP Drug Substance Forecast
10.4.5 Russia Market GMP Drug Substance Forecast
10.5 Middle East & Africa GMP Drug Substance Forecast by Region (2027-2032)
10.5.1 Egypt Market GMP Drug Substance Forecast
10.5.2 South Africa Market GMP Drug Substance Forecast
10.5.3 Israel Market GMP Drug Substance Forecast
10.5.4 Turkey Market GMP Drug Substance Forecast
10.6 Global GMP Drug Substance Forecast by Type (2027-2032)
10.7 Global GMP Drug Substance Forecast by Application (2027-2032)
10.7.1 GCC Countries Market GMP Drug Substance Forecast
11 KEY PLAYERS ANALYSIS
11.1 WuXi Biologics
11.1.1 WuXi Biologics Company Information
11.1.2 WuXi Biologics GMP Drug Substance Product Offered
11.1.3 WuXi Biologics GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 WuXi Biologics Main Business Overview
11.1.5 WuXi Biologics Latest Developments
11.2 Lonza
11.2.1 Lonza Company Information
11.2.2 Lonza GMP Drug Substance Product Offered
11.2.3 Lonza GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Lonza Main Business Overview
11.2.5 Lonza Latest Developments
11.3 Xikang(Wuhan)Biopharmaceutical
11.3.1 Xikang(Wuhan)Biopharmaceutical Company Information
11.3.2 Xikang(Wuhan)Biopharmaceutical GMP Drug Substance Product Offered
11.3.3 Xikang(Wuhan)Biopharmaceutical GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Xikang(Wuhan)Biopharmaceutical Main Business Overview
11.3.5 Xikang(Wuhan)Biopharmaceutical Latest Developments
11.4 Bioworkshops
11.4.1 Bioworkshops Company Information
11.4.2 Bioworkshops GMP Drug Substance Product Offered
11.4.3 Bioworkshops GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bioworkshops Main Business Overview
11.4.5 Bioworkshops Latest Developments
11.5 FUJIFILM Biotechnologies
11.5.1 FUJIFILM Biotechnologies Company Information
11.5.2 FUJIFILM Biotechnologies GMP Drug Substance Product Offered
11.5.3 FUJIFILM Biotechnologies GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 FUJIFILM Biotechnologies Main Business Overview
11.5.5 FUJIFILM Biotechnologies Latest Developments
11.6 Ardena
11.6.1 Ardena Company Information
11.6.2 Ardena GMP Drug Substance Product Offered
11.6.3 Ardena GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Ardena Main Business Overview
11.6.5 Ardena Latest Developments
11.7 Catalent Biologics
11.7.1 Catalent Biologics Company Information
11.7.2 Catalent Biologics GMP Drug Substance Product Offered
11.7.3 Catalent Biologics GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Catalent Biologics Main Business Overview
11.7.5 Catalent Biologics Latest Developments
11.8 Hovione
11.8.1 Hovione Company Information
11.8.2 Hovione GMP Drug Substance Product Offered
11.8.3 Hovione GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Hovione Main Business Overview
11.8.5 Hovione Latest Developments
11.9 Cambrex
11.9.1 Cambrex Company Information
11.9.2 Cambrex GMP Drug Substance Product Offered
11.9.3 Cambrex GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Cambrex Main Business Overview
11.9.5 Cambrex Latest Developments
11.10 Richter BioLogics
11.10.1 Richter BioLogics Company Information
11.10.2 Richter BioLogics GMP Drug Substance Product Offered
11.10.3 Richter BioLogics GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Richter BioLogics Main Business Overview
11.10.5 Richter BioLogics Latest Developments
11.11 Samsung Biologic
11.11.1 Samsung Biologic Company Information
11.11.2 Samsung Biologic GMP Drug Substance Product Offered
11.11.3 Samsung Biologic GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Samsung Biologic Main Business Overview
11.11.5 Samsung Biologic Latest Developments
11.12 CordenPharma
11.12.1 CordenPharma Company Information
11.12.2 CordenPharma GMP Drug Substance Product Offered
11.12.3 CordenPharma GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 CordenPharma Main Business Overview
11.12.5 CordenPharma Latest Developments
11.13 Mabion
11.13.1 Mabion Company Information
11.13.2 Mabion GMP Drug Substance Product Offered
11.13.3 Mabion GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Mabion Main Business Overview
11.13.5 Mabion Latest Developments
11.14 Shenzhen Letu Life Technology
11.14.1 Shenzhen Letu Life Technology Company Information
11.14.2 Shenzhen Letu Life Technology GMP Drug Substance Product Offered
11.14.3 Shenzhen Letu Life Technology GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Shenzhen Letu Life Technology Main Business Overview
11.14.5 Shenzhen Letu Life Technology Latest Developments
11.15 Bio-Thera Solutions
11.15.1 Bio-Thera Solutions Company Information
11.15.2 Bio-Thera Solutions GMP Drug Substance Product Offered
11.15.3 Bio-Thera Solutions GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Bio-Thera Solutions Main Business Overview
11.15.5 Bio-Thera Solutions Latest Developments
11.16 BioDlink Biopharm
11.16.1 BioDlink Biopharm Company Information
11.16.2 BioDlink Biopharm GMP Drug Substance Product Offered
11.16.3 BioDlink Biopharm GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 BioDlink Biopharm Main Business Overview
11.16.5 BioDlink Biopharm Latest Developments
11.17 Nanjing Probio Biotech
11.17.1 Nanjing Probio Biotech Company Information
11.17.2 Nanjing Probio Biotech GMP Drug Substance Product Offered
11.17.3 Nanjing Probio Biotech GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Nanjing Probio Biotech Main Business Overview
11.17.5 Nanjing Probio Biotech Latest Developments
11.18 Shanghai Henlius Biotech
11.18.1 Shanghai Henlius Biotech Company Information
11.18.2 Shanghai Henlius Biotech GMP Drug Substance Product Offered
11.18.3 Shanghai Henlius Biotech GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Shanghai Henlius Biotech Main Business Overview
11.18.5 Shanghai Henlius Biotech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GMP Drug Substance Market Size (2021-2032)
2.1.2 GMP Drug Substance Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for GMP Drug Substance by Country/Region (2021, 2025 & 2032)
2.2 GMP Drug Substance Segment by Type
2.2.1 Monoclonal Antibodies (mAbs)
2.2.2 Recombinant Proteins/enzymes
2.2.3 Antibody-drug Conjugates (ADCs)
2.2.4 Vaccines
2.2.5 Others
2.2.6 GMP Drug Substance Market Size by Type
2.2.6.1 GMP Drug Substance Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global GMP Drug Substance Market Size Market Share by Type (2021-2026)
2.3 GMP Drug Substance Segment by Application
2.3.1 Cancer
2.3.2 Diabetes
2.3.3 Disease Prevention
2.3.4 Rare Diseases
2.3.5 Others
2.3.6 GMP Drug Substance Market Size by Application
2.3.6.1 GMP Drug Substance Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.6.2 Global GMP Drug Substance Market Size Market Share by Application (2021-2026)
3 GMP DRUG SUBSTANCE MARKET SIZE BY PLAYER
3.1 GMP Drug Substance Market Size Market Share by Player
3.1.1 Global GMP Drug Substance Revenue by Player (2021-2026)
3.1.2 Global GMP Drug Substance Revenue Market Share by Player (2021-2026)
3.2 Global GMP Drug Substance Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GMP DRUG SUBSTANCE BY REGION
4.1 GMP Drug Substance Market Size by Region (2021-2026)
4.2 Global GMP Drug Substance Annual Revenue by Country/Region (2021-2026)
4.3 Americas GMP Drug Substance Market Size Growth (2021-2026)
4.4 APAC GMP Drug Substance Market Size Growth (2021-2026)
4.5 Europe GMP Drug Substance Market Size Growth (2021-2026)
4.6 Middle East & Africa GMP Drug Substance Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas GMP Drug Substance Market Size by Country (2021-2026)
5.2 Americas GMP Drug Substance Market Size by Type (2021-2026)
5.3 Americas GMP Drug Substance Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GMP Drug Substance Market Size by Region (2021-2026)
6.2 APAC GMP Drug Substance Market Size by Type (2021-2026)
6.3 APAC GMP Drug Substance Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe GMP Drug Substance Market Size by Country (2021-2026)
7.2 Europe GMP Drug Substance Market Size by Type (2021-2026)
7.3 Europe GMP Drug Substance Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GMP Drug Substance by Region (2021-2026)
8.2 Middle East & Africa GMP Drug Substance Market Size by Type (2021-2026)
8.3 Middle East & Africa GMP Drug Substance Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GMP DRUG SUBSTANCE MARKET FORECAST
10.1 Global GMP Drug Substance Forecast by Region (2027-2032)
10.1.1 Global GMP Drug Substance Forecast by Region (2027-2032)
10.1.2 Americas GMP Drug Substance Forecast
10.1.3 APAC GMP Drug Substance Forecast
10.1.4 Europe GMP Drug Substance Forecast
10.1.5 Middle East & Africa GMP Drug Substance Forecast
10.2 Americas GMP Drug Substance Forecast by Country (2027-2032)
10.2.1 United States Market GMP Drug Substance Forecast
10.2.2 Canada Market GMP Drug Substance Forecast
10.2.3 Mexico Market GMP Drug Substance Forecast
10.2.4 Brazil Market GMP Drug Substance Forecast
10.3 APAC GMP Drug Substance Forecast by Region (2027-2032)
10.3.1 China GMP Drug Substance Market Forecast
10.3.2 Japan Market GMP Drug Substance Forecast
10.3.3 Korea Market GMP Drug Substance Forecast
10.3.4 Southeast Asia Market GMP Drug Substance Forecast
10.3.5 India Market GMP Drug Substance Forecast
10.3.6 Australia Market GMP Drug Substance Forecast
10.4 Europe GMP Drug Substance Forecast by Country (2027-2032)
10.4.1 Germany Market GMP Drug Substance Forecast
10.4.2 France Market GMP Drug Substance Forecast
10.4.3 UK Market GMP Drug Substance Forecast
10.4.4 Italy Market GMP Drug Substance Forecast
10.4.5 Russia Market GMP Drug Substance Forecast
10.5 Middle East & Africa GMP Drug Substance Forecast by Region (2027-2032)
10.5.1 Egypt Market GMP Drug Substance Forecast
10.5.2 South Africa Market GMP Drug Substance Forecast
10.5.3 Israel Market GMP Drug Substance Forecast
10.5.4 Turkey Market GMP Drug Substance Forecast
10.6 Global GMP Drug Substance Forecast by Type (2027-2032)
10.7 Global GMP Drug Substance Forecast by Application (2027-2032)
10.7.1 GCC Countries Market GMP Drug Substance Forecast
11 KEY PLAYERS ANALYSIS
11.1 WuXi Biologics
11.1.1 WuXi Biologics Company Information
11.1.2 WuXi Biologics GMP Drug Substance Product Offered
11.1.3 WuXi Biologics GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 WuXi Biologics Main Business Overview
11.1.5 WuXi Biologics Latest Developments
11.2 Lonza
11.2.1 Lonza Company Information
11.2.2 Lonza GMP Drug Substance Product Offered
11.2.3 Lonza GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Lonza Main Business Overview
11.2.5 Lonza Latest Developments
11.3 Xikang(Wuhan)Biopharmaceutical
11.3.1 Xikang(Wuhan)Biopharmaceutical Company Information
11.3.2 Xikang(Wuhan)Biopharmaceutical GMP Drug Substance Product Offered
11.3.3 Xikang(Wuhan)Biopharmaceutical GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Xikang(Wuhan)Biopharmaceutical Main Business Overview
11.3.5 Xikang(Wuhan)Biopharmaceutical Latest Developments
11.4 Bioworkshops
11.4.1 Bioworkshops Company Information
11.4.2 Bioworkshops GMP Drug Substance Product Offered
11.4.3 Bioworkshops GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bioworkshops Main Business Overview
11.4.5 Bioworkshops Latest Developments
11.5 FUJIFILM Biotechnologies
11.5.1 FUJIFILM Biotechnologies Company Information
11.5.2 FUJIFILM Biotechnologies GMP Drug Substance Product Offered
11.5.3 FUJIFILM Biotechnologies GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 FUJIFILM Biotechnologies Main Business Overview
11.5.5 FUJIFILM Biotechnologies Latest Developments
11.6 Ardena
11.6.1 Ardena Company Information
11.6.2 Ardena GMP Drug Substance Product Offered
11.6.3 Ardena GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Ardena Main Business Overview
11.6.5 Ardena Latest Developments
11.7 Catalent Biologics
11.7.1 Catalent Biologics Company Information
11.7.2 Catalent Biologics GMP Drug Substance Product Offered
11.7.3 Catalent Biologics GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Catalent Biologics Main Business Overview
11.7.5 Catalent Biologics Latest Developments
11.8 Hovione
11.8.1 Hovione Company Information
11.8.2 Hovione GMP Drug Substance Product Offered
11.8.3 Hovione GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Hovione Main Business Overview
11.8.5 Hovione Latest Developments
11.9 Cambrex
11.9.1 Cambrex Company Information
11.9.2 Cambrex GMP Drug Substance Product Offered
11.9.3 Cambrex GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Cambrex Main Business Overview
11.9.5 Cambrex Latest Developments
11.10 Richter BioLogics
11.10.1 Richter BioLogics Company Information
11.10.2 Richter BioLogics GMP Drug Substance Product Offered
11.10.3 Richter BioLogics GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Richter BioLogics Main Business Overview
11.10.5 Richter BioLogics Latest Developments
11.11 Samsung Biologic
11.11.1 Samsung Biologic Company Information
11.11.2 Samsung Biologic GMP Drug Substance Product Offered
11.11.3 Samsung Biologic GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Samsung Biologic Main Business Overview
11.11.5 Samsung Biologic Latest Developments
11.12 CordenPharma
11.12.1 CordenPharma Company Information
11.12.2 CordenPharma GMP Drug Substance Product Offered
11.12.3 CordenPharma GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 CordenPharma Main Business Overview
11.12.5 CordenPharma Latest Developments
11.13 Mabion
11.13.1 Mabion Company Information
11.13.2 Mabion GMP Drug Substance Product Offered
11.13.3 Mabion GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Mabion Main Business Overview
11.13.5 Mabion Latest Developments
11.14 Shenzhen Letu Life Technology
11.14.1 Shenzhen Letu Life Technology Company Information
11.14.2 Shenzhen Letu Life Technology GMP Drug Substance Product Offered
11.14.3 Shenzhen Letu Life Technology GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Shenzhen Letu Life Technology Main Business Overview
11.14.5 Shenzhen Letu Life Technology Latest Developments
11.15 Bio-Thera Solutions
11.15.1 Bio-Thera Solutions Company Information
11.15.2 Bio-Thera Solutions GMP Drug Substance Product Offered
11.15.3 Bio-Thera Solutions GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Bio-Thera Solutions Main Business Overview
11.15.5 Bio-Thera Solutions Latest Developments
11.16 BioDlink Biopharm
11.16.1 BioDlink Biopharm Company Information
11.16.2 BioDlink Biopharm GMP Drug Substance Product Offered
11.16.3 BioDlink Biopharm GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 BioDlink Biopharm Main Business Overview
11.16.5 BioDlink Biopharm Latest Developments
11.17 Nanjing Probio Biotech
11.17.1 Nanjing Probio Biotech Company Information
11.17.2 Nanjing Probio Biotech GMP Drug Substance Product Offered
11.17.3 Nanjing Probio Biotech GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Nanjing Probio Biotech Main Business Overview
11.17.5 Nanjing Probio Biotech Latest Developments
11.18 Shanghai Henlius Biotech
11.18.1 Shanghai Henlius Biotech Company Information
11.18.2 Shanghai Henlius Biotech GMP Drug Substance Product Offered
11.18.3 Shanghai Henlius Biotech GMP Drug Substance Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Shanghai Henlius Biotech Main Business Overview
11.18.5 Shanghai Henlius Biotech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. GMP Drug Substance Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. GMP Drug Substance Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies (mAbs)
Table 4. Major Players of Recombinant Proteins/enzymes
Table 5. Major Players of Antibody-drug Conjugates (ADCs)
Table 6. Major Players of Vaccines
Table 7. Major Players of Others
Table 8. GMP Drug Substance Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global GMP Drug Substance Market Size by Type (2021-2026) & ($ millions)
Table 10. Global GMP Drug Substance Market Size Market Share by Type (2021-2026)
Table 11. GMP Drug Substance Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global GMP Drug Substance Market Size by Application (2021-2026) & ($ millions)
Table 13. Global GMP Drug Substance Market Size Market Share by Application (2021-2026)
Table 14. Global GMP Drug Substance Revenue by Player (2021-2026) & ($ millions)
Table 15. Global GMP Drug Substance Revenue Market Share by Player (2021-2026)
Table 16. GMP Drug Substance Key Players Head office and Products Offered
Table 17. GMP Drug Substance Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global GMP Drug Substance Market Size by Region (2021-2026) & ($ millions)
Table 21. Global GMP Drug Substance Market Size Market Share by Region (2021-2026)
Table 22. Global GMP Drug Substance Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global GMP Drug Substance Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas GMP Drug Substance Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas GMP Drug Substance Market Size Market Share by Country (2021-2026)
Table 26. Americas GMP Drug Substance Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas GMP Drug Substance Market Size Market Share by Type (2021-2026)
Table 28. Americas GMP Drug Substance Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas GMP Drug Substance Market Size Market Share by Application (2021-2026)
Table 30. APAC GMP Drug Substance Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC GMP Drug Substance Market Size Market Share by Region (2021-2026)
Table 32. APAC GMP Drug Substance Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC GMP Drug Substance Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe GMP Drug Substance Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe GMP Drug Substance Market Size Market Share by Country (2021-2026)
Table 36. Europe GMP Drug Substance Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe GMP Drug Substance Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa GMP Drug Substance Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa GMP Drug Substance Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa GMP Drug Substance Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of GMP Drug Substance
Table 42. Key Market Challenges & Risks of GMP Drug Substance
Table 43. Key Industry Trends of GMP Drug Substance
Table 44. Global GMP Drug Substance Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global GMP Drug Substance Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global GMP Drug Substance Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global GMP Drug Substance Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. WuXi Biologics Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 49. WuXi Biologics GMP Drug Substance Product Offered
Table 50. WuXi Biologics GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. WuXi Biologics Main Business
Table 52. WuXi Biologics Latest Developments
Table 53. Lonza Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 54. Lonza GMP Drug Substance Product Offered
Table 55. Lonza GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Lonza Main Business
Table 57. Lonza Latest Developments
Table 58. Xikang(Wuhan)Biopharmaceutical Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 59. Xikang(Wuhan)Biopharmaceutical GMP Drug Substance Product Offered
Table 60. Xikang(Wuhan)Biopharmaceutical GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Xikang(Wuhan)Biopharmaceutical Main Business
Table 62. Xikang(Wuhan)Biopharmaceutical Latest Developments
Table 63. Bioworkshops Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 64. Bioworkshops GMP Drug Substance Product Offered
Table 65. Bioworkshops GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Bioworkshops Main Business
Table 67. Bioworkshops Latest Developments
Table 68. FUJIFILM Biotechnologies Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 69. FUJIFILM Biotechnologies GMP Drug Substance Product Offered
Table 70. FUJIFILM Biotechnologies GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. FUJIFILM Biotechnologies Main Business
Table 72. FUJIFILM Biotechnologies Latest Developments
Table 73. Ardena Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 74. Ardena GMP Drug Substance Product Offered
Table 75. Ardena GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Ardena Main Business
Table 77. Ardena Latest Developments
Table 78. Catalent Biologics Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 79. Catalent Biologics GMP Drug Substance Product Offered
Table 80. Catalent Biologics GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Catalent Biologics Main Business
Table 82. Catalent Biologics Latest Developments
Table 83. Hovione Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 84. Hovione GMP Drug Substance Product Offered
Table 85. Hovione GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Hovione Main Business
Table 87. Hovione Latest Developments
Table 88. Cambrex Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 89. Cambrex GMP Drug Substance Product Offered
Table 90. Cambrex GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Cambrex Main Business
Table 92. Cambrex Latest Developments
Table 93. Richter BioLogics Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 94. Richter BioLogics GMP Drug Substance Product Offered
Table 95. Richter BioLogics GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Richter BioLogics Main Business
Table 97. Richter BioLogics Latest Developments
Table 98. Samsung Biologic Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 99. Samsung Biologic GMP Drug Substance Product Offered
Table 100. Samsung Biologic GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Samsung Biologic Main Business
Table 102. Samsung Biologic Latest Developments
Table 103. CordenPharma Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 104. CordenPharma GMP Drug Substance Product Offered
Table 105. CordenPharma GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. CordenPharma Main Business
Table 107. CordenPharma Latest Developments
Table 108. Mabion Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 109. Mabion GMP Drug Substance Product Offered
Table 110. Mabion GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Mabion Main Business
Table 112. Mabion Latest Developments
Table 113. Shenzhen Letu Life Technology Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 114. Shenzhen Letu Life Technology GMP Drug Substance Product Offered
Table 115. Shenzhen Letu Life Technology GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Shenzhen Letu Life Technology Main Business
Table 117. Shenzhen Letu Life Technology Latest Developments
Table 118. Bio-Thera Solutions Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 119. Bio-Thera Solutions GMP Drug Substance Product Offered
Table 120. Bio-Thera Solutions GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Bio-Thera Solutions Main Business
Table 122. Bio-Thera Solutions Latest Developments
Table 123. BioDlink Biopharm Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 124. BioDlink Biopharm GMP Drug Substance Product Offered
Table 125. BioDlink Biopharm GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. BioDlink Biopharm Main Business
Table 127. BioDlink Biopharm Latest Developments
Table 128. Nanjing Probio Biotech Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 129. Nanjing Probio Biotech GMP Drug Substance Product Offered
Table 130. Nanjing Probio Biotech GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Nanjing Probio Biotech Main Business
Table 132. Nanjing Probio Biotech Latest Developments
Table 133. Shanghai Henlius Biotech Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 134. Shanghai Henlius Biotech GMP Drug Substance Product Offered
Table 135. Shanghai Henlius Biotech GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Shanghai Henlius Biotech Main Business
Table 137. Shanghai Henlius Biotech Latest Developments
Table 1. GMP Drug Substance Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. GMP Drug Substance Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies (mAbs)
Table 4. Major Players of Recombinant Proteins/enzymes
Table 5. Major Players of Antibody-drug Conjugates (ADCs)
Table 6. Major Players of Vaccines
Table 7. Major Players of Others
Table 8. GMP Drug Substance Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global GMP Drug Substance Market Size by Type (2021-2026) & ($ millions)
Table 10. Global GMP Drug Substance Market Size Market Share by Type (2021-2026)
Table 11. GMP Drug Substance Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global GMP Drug Substance Market Size by Application (2021-2026) & ($ millions)
Table 13. Global GMP Drug Substance Market Size Market Share by Application (2021-2026)
Table 14. Global GMP Drug Substance Revenue by Player (2021-2026) & ($ millions)
Table 15. Global GMP Drug Substance Revenue Market Share by Player (2021-2026)
Table 16. GMP Drug Substance Key Players Head office and Products Offered
Table 17. GMP Drug Substance Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global GMP Drug Substance Market Size by Region (2021-2026) & ($ millions)
Table 21. Global GMP Drug Substance Market Size Market Share by Region (2021-2026)
Table 22. Global GMP Drug Substance Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global GMP Drug Substance Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas GMP Drug Substance Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas GMP Drug Substance Market Size Market Share by Country (2021-2026)
Table 26. Americas GMP Drug Substance Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas GMP Drug Substance Market Size Market Share by Type (2021-2026)
Table 28. Americas GMP Drug Substance Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas GMP Drug Substance Market Size Market Share by Application (2021-2026)
Table 30. APAC GMP Drug Substance Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC GMP Drug Substance Market Size Market Share by Region (2021-2026)
Table 32. APAC GMP Drug Substance Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC GMP Drug Substance Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe GMP Drug Substance Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe GMP Drug Substance Market Size Market Share by Country (2021-2026)
Table 36. Europe GMP Drug Substance Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe GMP Drug Substance Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa GMP Drug Substance Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa GMP Drug Substance Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa GMP Drug Substance Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of GMP Drug Substance
Table 42. Key Market Challenges & Risks of GMP Drug Substance
Table 43. Key Industry Trends of GMP Drug Substance
Table 44. Global GMP Drug Substance Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global GMP Drug Substance Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global GMP Drug Substance Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global GMP Drug Substance Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. WuXi Biologics Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 49. WuXi Biologics GMP Drug Substance Product Offered
Table 50. WuXi Biologics GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. WuXi Biologics Main Business
Table 52. WuXi Biologics Latest Developments
Table 53. Lonza Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 54. Lonza GMP Drug Substance Product Offered
Table 55. Lonza GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Lonza Main Business
Table 57. Lonza Latest Developments
Table 58. Xikang(Wuhan)Biopharmaceutical Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 59. Xikang(Wuhan)Biopharmaceutical GMP Drug Substance Product Offered
Table 60. Xikang(Wuhan)Biopharmaceutical GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Xikang(Wuhan)Biopharmaceutical Main Business
Table 62. Xikang(Wuhan)Biopharmaceutical Latest Developments
Table 63. Bioworkshops Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 64. Bioworkshops GMP Drug Substance Product Offered
Table 65. Bioworkshops GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Bioworkshops Main Business
Table 67. Bioworkshops Latest Developments
Table 68. FUJIFILM Biotechnologies Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 69. FUJIFILM Biotechnologies GMP Drug Substance Product Offered
Table 70. FUJIFILM Biotechnologies GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. FUJIFILM Biotechnologies Main Business
Table 72. FUJIFILM Biotechnologies Latest Developments
Table 73. Ardena Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 74. Ardena GMP Drug Substance Product Offered
Table 75. Ardena GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Ardena Main Business
Table 77. Ardena Latest Developments
Table 78. Catalent Biologics Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 79. Catalent Biologics GMP Drug Substance Product Offered
Table 80. Catalent Biologics GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Catalent Biologics Main Business
Table 82. Catalent Biologics Latest Developments
Table 83. Hovione Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 84. Hovione GMP Drug Substance Product Offered
Table 85. Hovione GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Hovione Main Business
Table 87. Hovione Latest Developments
Table 88. Cambrex Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 89. Cambrex GMP Drug Substance Product Offered
Table 90. Cambrex GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Cambrex Main Business
Table 92. Cambrex Latest Developments
Table 93. Richter BioLogics Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 94. Richter BioLogics GMP Drug Substance Product Offered
Table 95. Richter BioLogics GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Richter BioLogics Main Business
Table 97. Richter BioLogics Latest Developments
Table 98. Samsung Biologic Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 99. Samsung Biologic GMP Drug Substance Product Offered
Table 100. Samsung Biologic GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Samsung Biologic Main Business
Table 102. Samsung Biologic Latest Developments
Table 103. CordenPharma Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 104. CordenPharma GMP Drug Substance Product Offered
Table 105. CordenPharma GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. CordenPharma Main Business
Table 107. CordenPharma Latest Developments
Table 108. Mabion Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 109. Mabion GMP Drug Substance Product Offered
Table 110. Mabion GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Mabion Main Business
Table 112. Mabion Latest Developments
Table 113. Shenzhen Letu Life Technology Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 114. Shenzhen Letu Life Technology GMP Drug Substance Product Offered
Table 115. Shenzhen Letu Life Technology GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Shenzhen Letu Life Technology Main Business
Table 117. Shenzhen Letu Life Technology Latest Developments
Table 118. Bio-Thera Solutions Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 119. Bio-Thera Solutions GMP Drug Substance Product Offered
Table 120. Bio-Thera Solutions GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Bio-Thera Solutions Main Business
Table 122. Bio-Thera Solutions Latest Developments
Table 123. BioDlink Biopharm Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 124. BioDlink Biopharm GMP Drug Substance Product Offered
Table 125. BioDlink Biopharm GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. BioDlink Biopharm Main Business
Table 127. BioDlink Biopharm Latest Developments
Table 128. Nanjing Probio Biotech Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 129. Nanjing Probio Biotech GMP Drug Substance Product Offered
Table 130. Nanjing Probio Biotech GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Nanjing Probio Biotech Main Business
Table 132. Nanjing Probio Biotech Latest Developments
Table 133. Shanghai Henlius Biotech Details, Company Type, GMP Drug Substance Area Served and Its Competitors
Table 134. Shanghai Henlius Biotech GMP Drug Substance Product Offered
Table 135. Shanghai Henlius Biotech GMP Drug Substance Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Shanghai Henlius Biotech Main Business
Table 137. Shanghai Henlius Biotech Latest Developments
LIST OF FIGURES
Figure 1. GMP Drug Substance Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global GMP Drug Substance Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. GMP Drug Substance Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. GMP Drug Substance Sales Market Share by Country/Region (2025)
Figure 8. GMP Drug Substance Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global GMP Drug Substance Market Size Market Share by Type in 2025
Figure 10. GMP Drug Substance in Cancer
Figure 11. Global GMP Drug Substance Market: Cancer (2021-2026) & ($ millions)
Figure 12. GMP Drug Substance in Diabetes
Figure 13. Global GMP Drug Substance Market: Diabetes (2021-2026) & ($ millions)
Figure 14. GMP Drug Substance in Disease Prevention
Figure 15. Global GMP Drug Substance Market: Disease Prevention (2021-2026) & ($ millions)
Figure 16. GMP Drug Substance in Rare Diseases
Figure 17. Global GMP Drug Substance Market: Rare Diseases (2021-2026) & ($ millions)
Figure 18. GMP Drug Substance in Others
Figure 19. Global GMP Drug Substance Market: Others (2021-2026) & ($ millions)
Figure 20. Global GMP Drug Substance Market Size Market Share by Application in 2025
Figure 21. Global GMP Drug Substance Revenue Market Share by Player in 2025
Figure 22. Global GMP Drug Substance Market Size Market Share by Region (2021-2026)
Figure 23. Americas GMP Drug Substance Market Size 2021-2026 ($ millions)
Figure 24. APAC GMP Drug Substance Market Size 2021-2026 ($ millions)
Figure 25. Europe GMP Drug Substance Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa GMP Drug Substance Market Size 2021-2026 ($ millions)
Figure 27. Americas GMP Drug Substance Value Market Share by Country in 2025
Figure 28. United States GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC GMP Drug Substance Market Size Market Share by Region in 2025
Figure 33. APAC GMP Drug Substance Market Size Market Share by Type (2021-2026)
Figure 34. APAC GMP Drug Substance Market Size Market Share by Application (2021-2026)
Figure 35. China GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 39. India GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe GMP Drug Substance Market Size Market Share by Country in 2025
Figure 42. Europe GMP Drug Substance Market Size Market Share by Type (2021-2026)
Figure 43. Europe GMP Drug Substance Market Size Market Share by Application (2021-2026)
Figure 44. Germany GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 45. France GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 46. UK GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa GMP Drug Substance Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa GMP Drug Substance Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa GMP Drug Substance Market Size Market Share by Application (2021-2026)
Figure 52. Egypt GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 58. APAC GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 59. Europe GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 61. United States GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 62. Canada GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 63. Mexico GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 64. Brazil GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 65. China GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 66. Japan GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 67. Korea GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 69. India GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 70. Australia GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 71. Germany GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 72. France GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 73. UK GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 74. Italy GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 75. Russia GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 76. Egypt GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 77. South Africa GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 78. Israel GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 79. Turkey GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 80. Global GMP Drug Substance Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global GMP Drug Substance Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 1. GMP Drug Substance Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global GMP Drug Substance Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. GMP Drug Substance Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. GMP Drug Substance Sales Market Share by Country/Region (2025)
Figure 8. GMP Drug Substance Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global GMP Drug Substance Market Size Market Share by Type in 2025
Figure 10. GMP Drug Substance in Cancer
Figure 11. Global GMP Drug Substance Market: Cancer (2021-2026) & ($ millions)
Figure 12. GMP Drug Substance in Diabetes
Figure 13. Global GMP Drug Substance Market: Diabetes (2021-2026) & ($ millions)
Figure 14. GMP Drug Substance in Disease Prevention
Figure 15. Global GMP Drug Substance Market: Disease Prevention (2021-2026) & ($ millions)
Figure 16. GMP Drug Substance in Rare Diseases
Figure 17. Global GMP Drug Substance Market: Rare Diseases (2021-2026) & ($ millions)
Figure 18. GMP Drug Substance in Others
Figure 19. Global GMP Drug Substance Market: Others (2021-2026) & ($ millions)
Figure 20. Global GMP Drug Substance Market Size Market Share by Application in 2025
Figure 21. Global GMP Drug Substance Revenue Market Share by Player in 2025
Figure 22. Global GMP Drug Substance Market Size Market Share by Region (2021-2026)
Figure 23. Americas GMP Drug Substance Market Size 2021-2026 ($ millions)
Figure 24. APAC GMP Drug Substance Market Size 2021-2026 ($ millions)
Figure 25. Europe GMP Drug Substance Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa GMP Drug Substance Market Size 2021-2026 ($ millions)
Figure 27. Americas GMP Drug Substance Value Market Share by Country in 2025
Figure 28. United States GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC GMP Drug Substance Market Size Market Share by Region in 2025
Figure 33. APAC GMP Drug Substance Market Size Market Share by Type (2021-2026)
Figure 34. APAC GMP Drug Substance Market Size Market Share by Application (2021-2026)
Figure 35. China GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 39. India GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe GMP Drug Substance Market Size Market Share by Country in 2025
Figure 42. Europe GMP Drug Substance Market Size Market Share by Type (2021-2026)
Figure 43. Europe GMP Drug Substance Market Size Market Share by Application (2021-2026)
Figure 44. Germany GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 45. France GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 46. UK GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa GMP Drug Substance Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa GMP Drug Substance Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa GMP Drug Substance Market Size Market Share by Application (2021-2026)
Figure 52. Egypt GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries GMP Drug Substance Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 58. APAC GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 59. Europe GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 61. United States GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 62. Canada GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 63. Mexico GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 64. Brazil GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 65. China GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 66. Japan GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 67. Korea GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 69. India GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 70. Australia GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 71. Germany GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 72. France GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 73. UK GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 74. Italy GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 75. Russia GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 76. Egypt GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 77. South Africa GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 78. Israel GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 79. Turkey GMP Drug Substance Market Size 2027-2032 ($ millions)
Figure 80. Global GMP Drug Substance Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global GMP Drug Substance Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries GMP Drug Substance Market Size 2027-2032 ($ millions)
